MedPath

The Effectiveness of Emotional Disclosure on Depression, Anxiety and Stress and Quality of Life in Women after Abortio

Not Applicable
Recruiting
Conditions
Condition 1: depression. Condition 2: anxiety. Condition 3: stress.
Major depressive disorder, single episode, mild
Generalized anxiety disorder
Acute stress reaction
F32.0
F41.1
F43.0
Registration Number
IRCT20210528051421N1
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
70
Inclusion Criteria

1-Women who have had a miscarriage within 48-24 hours.
2- Will be willing to participate in the study and complete the informed consent form.
3- Be a Muslim and an Iranian.
4- To be 18-45 years old.
5- Pregnancy is the desire of the couple.
6- Does not have chronic physical diseases.
7 - Do not have a disability.
8- Has no other psychological disorders.
9- Be literate.
10- Do not have major stressful events in the last 6 months.
11- Has not taken sedatives and psychotropic drugs in the last 6 months.
12- Not addicted to drugs, tobacco and alcohol.
13- Have a spouse and live with his.
14- Has no history of infertility.
15- Depression score between 10-20 (mild and moderate depression) has been obtained from the Depression, Anxiety and Stress Questionnaire 21-DASS.
16- Anxiety score higher than 7 (mild anxiety up) has been obtained from the Depression, Anxiety and Stress Questionnaire 21-DASS.
17- Stress score higher than 14 (mild stress upwards) has obtained from the Depression, Anxiety and Stress Questionnaire 21-DASS.

Exclusion Criteria

Unable to write, speak or listen.
Have severe physical complications from abortion.
Do not have access to a mobile phone.
Be pregnant with assisted reproductive techniques.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Depression score in Anxiety, Stress, Depression Questionnaire (DASS -21). Timepoint: Before the intervention, end of the intervention and one month after the intervention. Method of measurement: Anxiety, stress, depression questionnaire ( DASS -21).;Anxiety score in Anxiety, Stress, Depression Questionnaire (DASS -21). Timepoint: Before the intervention, end of the intervention and one month after the intervention. Method of measurement: Anxiety, stress, depression questionnaire ( DASS -21).;Stress score in Anxiety, Stress, Depression Questionnaire (DASS -21). Timepoint: Before the intervention, end of the intervention and one month after the intervention. Method of measurement: Anxiety, stress, depression questionnaire ( DASS -21).;Quality of life score in the World Health Organization quality of life questionnaire. Timepoint: Before the intervention, end of the intervention and one month after the intervention. Method of measurement: World Health Organization Quality of Life Questionnaire - Short Form.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath